You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2024

Details for Patent: 7,452,874


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,452,874
Title:Thrombopoietin mimetics
Abstract:Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
Inventor(s): Duffy; Kevin J. (Collegeville, PA), Luengo; Juan I. (Collegeville, PA), Shaw; Antony N. (Collegeville, PA), Wiggall; Kenneth (Collegeville, PA)
Assignee: SmithKline Beecham Corp. (Philadelphia, PA)
Application Number:11/650,838
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,452,874
Patent Claim Types:
see list of patent claims
Compound; Composition; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,452,874: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 7,452,874, focusing on its claims, scope, and the broader patent landscape.

Overview of the Patent

Patent Title and Inventors

United States Patent 7,452,874, titled "Thrombopoietin Mimetics," was invented by a team of researchers. This patent involves the invention of non-peptide thrombopoietin (TPO) mimetics, along with novel processes and intermediates used in their preparation[5].

Claims Analysis

Independent and Dependent Claims

The patent includes a set of claims that define the scope of the invention. These claims are categorized into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. For example, Claim 1 might describe the general structure and function of the non-peptide TPO mimetics.
  • Dependent Claims: These claims refer back to and further limit the independent claims. For instance, Claim 2 might specify a particular embodiment or application of the TPO mimetics described in Claim 1[5].

Claim Construction

The construction of claims is critical as it determines the breadth of protection afforded by the patent. Claims must be clear, concise, and definite to avoid ambiguity. In the case of US 7,452,874, the claims would be analyzed to ensure they meet these criteria and to understand the specific aspects of the TPO mimetics that are protected.

Scope of the Patent

Subject Matter

The scope of the patent is defined by the subject matter covered in the claims. For US 7,452,874, this includes non-peptide compounds that mimic the activity of thrombopoietin, a hormone that stimulates the production of platelets. The scope also encompasses the processes and intermediates involved in the synthesis of these compounds.

Novelty and Non-Obviousness

To be patentable, the invention must be novel and non-obvious. The scope of the patent ensures that the claimed subject matter is new and not obvious to a person of ordinary skill in the relevant field. This is particularly important in the pharmaceutical and biotechnology sectors, where small variations can lead to significant differences in efficacy and safety.

Patent Landscape

Prior Art

Understanding the prior art is essential to assess the novelty and non-obviousness of the invention. Prior art includes all publicly available information that existed before the filing date of the patent application. For US 7,452,874, a thorough search of existing patents, publications, and other relevant documents would have been conducted to ensure that the claimed TPO mimetics were not previously disclosed[1][4].

Global Patent Family

The patent landscape also involves examining the global patent family for US 7,452,874. This includes looking at related applications filed in other countries through services like the Global Dossier provided by the USPTO. This tool allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices, along with dossier, classification, and citation data[1].

Search Tools and Resources

USPTO Search Tools

Several tools are available for searching patents, including the Patent Public Search tool, which replaced legacy search tools like PubEast and PubWest. This tool provides enhanced access to prior art and is a powerful resource for conducting preliminary patent searches[1].

International Patent Databases

In addition to USPTO resources, international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) are crucial for a comprehensive search. These databases offer access to machine translations of patents in various languages, facilitating global patent searches[1].

Economic and Strategic Implications

Market Impact

The patent on TPO mimetics can have significant market implications, particularly in the treatment of thrombocytopenia and other platelet-related disorders. The exclusive rights granted by the patent can influence market competition and pricing strategies.

Licensing and Collaboration

The scope and claims of the patent also affect licensing and collaboration opportunities. Companies may seek to license the technology or collaborate with the patent holders to develop new treatments, which can be facilitated or hindered by the breadth and specificity of the claims.

Legal Considerations

Patent Litigation

Understanding the scope and claims of a patent is vital for avoiding patent litigation. Companies must ensure that their products or processes do not infringe on the claims of US 7,452,874. This involves a detailed analysis of the patent claims and comparing them with their own technologies.

Office Actions and Examinations

During the patent examination process, office actions may be issued if the examiner finds issues with the claims. Understanding these actions and responding appropriately is crucial to securing patent protection. Tools like the Patent Examination Data System (PEDS) can provide insights into the examination process and help in preparing responses to office actions[1].

Historical Context

Evolution of Patent Law

The patent landscape has evolved significantly over the years, influenced by changes in patent law and policy. Historical patents, such as those listed in the "Digest of Patents: 1790 to 1839," provide a context for how patent law has developed and how it impacts current patents like US 7,452,874[4].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Scope of the Patent: The subject matter covered includes non-peptide TPO mimetics and their synthesis processes.
  • Prior Art: A thorough search of prior art is essential to ensure novelty and non-obviousness.
  • Global Patent Family: Examining related applications globally helps in understanding the broader patent landscape.
  • Economic and Strategic Implications: The patent can significantly impact market competition and licensing opportunities.
  • Legal Considerations: Detailed analysis of claims is vital for avoiding litigation and navigating office actions.

FAQs

What is the main subject matter of US Patent 7,452,874?

The main subject matter of US Patent 7,452,874 is non-peptide thrombopoietin (TPO) mimetics and the processes and intermediates used in their preparation.

How can I search for prior art related to this patent?

You can use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the EPO, JPO, and WIPO to search for prior art.

What are the economic implications of this patent?

The patent can have significant market implications, influencing competition and pricing strategies in the treatment of thrombocytopenia and other platelet-related disorders.

How do I ensure my product does not infringe on the claims of US 7,452,874?

You should conduct a detailed analysis of the patent claims and compare them with your product or process to ensure there is no infringement.

Where can I find historical patents related to this field?

Historical patents can be found through resources such as the New York Public Library's SIBL, which provides access to early U.S. patents and other historical patent documents[4].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. US Courts - Report on Filing Patent/Trademark: https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NYPL Libguides - How to Search for an Historical U.S. Patent: https://libguides.nypl.org/patents/historical_patents
  5. Unified Patents - US-7452874-B2: https://portal.unifiedpatents.com/patents/patent/US-7452874-B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,452,874

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,452,874

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1294378 ⤷  Subscribe C300451 Netherlands ⤷  Subscribe
European Patent Office 1294378 ⤷  Subscribe CA 2010 00017 Denmark ⤷  Subscribe
European Patent Office 1294378 ⤷  Subscribe 91681 Luxembourg ⤷  Subscribe
European Patent Office 1294378 ⤷  Subscribe SPC020/2010 Ireland ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.